Targeting Tau in Alzheimer’s Disease and Related Disorders 2017

Title: Targeting Tau in Alzheimer’s Disease and Related Disorders

Time: Monday, March 13 9:00 AM – 5:00 PM

Location: The New York Academy of Sciences


Audience: Adults
Information:  The microtubule associated protein tau (MAPT) is a key mediator of neurodegeneration in Alzheimer’s disease and related disorders. This symposium will address the potential of tau-related targets for immunotherapy, across the spectrum of tauopathies. We will review the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic strategy for Alzheimer’s disease and other devastating neurodegenerative disorders.

Link to more information/website: